A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Link
https://link.springer.com/content/pdf/10.1007/s40262-022-01138-x.pdf
Reference22 articles.
1. Leger F, Debord J, Le Meur Y, Rousseau A, Buchler M, Lachatre G, et al. Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants. Clin Pharmacokinet. 2002;41:71–80.
2. Marquet P, Destère A, Monchaud C, Rérolle J-P, Buchler M, Mazouz H, et al. Clinical pharmacokinetics and Bayesian estimators for the individual dose adjustment of a generic formulation of tacrolimus in adult kidney transplant recipients. Clin Pharmacokinet. 2021;60:611–22.
3. Guo W, Yu Z, Gao Y, Lan X, Zang Y, Yu P, et al. A machine learning model to predict risperidone active moiety concentration based on initial therapeutic drug monitoring. Front Psychiatry. 2021;12: 711868.
4. Woillard J, Labriffe M, Debord J, Marquet P. Tacrolimus exposure prediction using machine learning. Clin Pharmacol Ther. 2021;110:361–9.
5. Sibieude E, Khandelwal A, Girard P, Hesthaven JS, Terranova N. Population pharmacokinetic model selection assisted by machine learning. J Pharmacokinet Pharmacodyn. 2022;49:257–70.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Machine Learning and Artificial Intelligence in PK‐PD Modeling: Fad, Friend, or Foe?;Clinical Pharmacology & Therapeutics;2024-01-05
2. Evaluating Use of Artificial Intelligence for Drug Exposure and Effect Prediction;Kidney International Reports;2024-01
3. Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence;Kidney International Reports;2024-01
4. Bridging the Worlds of Pharmacometrics and Machine Learning;Clinical Pharmacokinetics;2023-10-06
5. Bridging the Worlds of Pharmacometrics and Machine Learning;CLIN PHARMACOKINET;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3